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Introduction
Despite their enormous proliferative capacity, most hematopoietic stem cells (HSCs) reside in a non-cycling quiescent state, at any given time point 1 . This is of outmost importance to ensure life-long hematopoiesis and to protect the HSC pool from myelotoxic insult and premature exhaustion under conditions of hematopoietic stress 2, 3 . The naturally quiescent state of HSCs is believed to be controlled by negative regulators of cell proliferation. Studies using knockout mice have shown that endogenous levels of the cyclin dependent kinase (CDK) inhibitor p21 are crucial in order to maintain quiescence of HSCs and to protect the stem cell pool from exhaustion during stressed conditions 4 . The extrinsic signals that mediate these functions in vivo have not been identified. However, a main candidate based on a number of studies in vitro is the inhibitory cytokine transforming growth factor-β (TGF-β). TGF-β has been shown to induce cell cycle arrest in many cell types through upregulation of CDK inhibitors, including p21 5 . Moreover, active TGF-β induces quiescence of primitive hematopoietic progenitor cells in culture while TGF-β neutralization releases these cells from quiescence [6] [7] [8] [9] [10] [11] . In order to study how TGF-β regulates HSCs in vivo we generated conditional knockout mice for the TGF-β type I receptor (TβRI). We recently reported that TGF-β receptor-deficient HSCs, unexpectedly, had normal ability to regenerate the hematopoietic system following bone marrow transplantation 12 . However, when assayed in vitro, these cells had significantly enhanced proliferative capacity consistent with an important, yet highly context-dependent, role for TGF-β in regulation of HSCs 12 . In the present study we have specifically asked how TGF-β signaling influences the quiescent state of HSCs under conditions of hematopoietic stress to determine whether TGF-β plays a role in protection of the stem cell pool in vivo. The susceptibility of TGF-β receptor deficient
HSCs to cell cycle-specific myelotoxic injury has been tested as well as their ability to reconstitute serially transplanted mice. Our results clearly demonstrate that quiescence of HSCs and maintenance of the stem cell pool is not dependent on TGF-β signaling in vivo.
Materials and Methods

Mice
Genotyping and polyIC induction of TβRI floxed mice carrying MxCre has been described previously 12 . In order to overcome the inflammatory disease associated with lack of TGF-β signaling in T cells the mice were bred on to a αβ T-cell deficient background [13] [14] [15] . In addition, mice used in this study had been backcrossed on C57BL/6 background for at least six generations.
Competitive transplantation and 5-fluorouracil treatment
Bone marrow (BM) cells were harvested from femurs and tibiae and 5 
Flow cytometry
Flow cytometry for detection of Ly5.1 and Ly5.2 markers was carried out as previously described 12 .
Serial transplantations
For each consecutive BM transplantation 2 x 10 6 BM cells were injected into lethally irradiated recipients. Mice were monitored for survival for 2-3 months and then sacrificed for subsequent BM transfers.
Results and discussion
To mice, all expressing the Ly5.2 cell surface marker, were transplanted along with equal numbers of competitor cells (Ly5.1) into lethally irradiated recipients ( Fig 1A) . As expected from previous work TβRI null and control BM cells reconstituted primary mice with a similar efficiency after 12 weeks (Fig 1B) . We next administered two doses of 5-FU to half of the reconstituted mice with a five-day interval ( Figure 1A ). 5-FU kills a majority of cycling progenitors causing a recruitment of HSCs into proliferation 16 . Upon the second treatment, the fraction of HSCs that had been recruited into cell cycle would be killed. We hypothesized that TGF-β signaling deficient HSCs would be more prone to enter cell cycle following the first 5-FU treatment and that a larger fraction of the stem cell pool would be killed by the second treatment. This would then be read out as lower competitive repopulation ability when bone marrow from the 5-FU treated primary recipients was transplanted into secondary recipients (Fig 1A) . However no significant difference in Ly5.2 contribution between TβRI null and control groups was observed when these mice were analyzed after 14 weeks ( Figure 1C) . Thus, TGF-β receptor-deficient HSCs were equally susceptible, compared to controls, to repeated treatments with 5-FU suggesting that quiescence and the relative restriction to cell cycle entry is not dependent on TGF-β.
Since quiescence of HSCs is associated with maintenance of the stem cell pool we performed serial BM transplantations in order to ask whether the subsequent consumption of the stem cell pool would be altered in recipients of TGF-β signalingdeficient BM. BM from five donor mice of each genotype was transplanted into three lethally irradiated recipients for each donor. Mice were monitored for survival for two to three months and then sacrificed for subsequent BM transfers. A total of five consecutive BM transplantations were performed in order to provoke exhaustion of the stem cell pool. After the 4 th serial transplantation 50% of the mice died within 4 weeks in both groups, while less than 20 % remained after the 5 th transplant in both TβRI null and control groups (Fig 2) . This clearly demonstrates a normal 
